戻る
Roche Holding AG (RHHVF)価格
RHHVF 株価推移チャート
RHHVF 収入
Roche Holding AG
$439.16
-0.51%
$-2.29
終値： Jan 16, 16:00:00 GMT-5
$439.16
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
A-
最終スコア
主要データ
前終値
$441.45
始値
$430
当日レンジ
$430 - $439.16
52週レンジ
$277 - $442.36
取引高
32
平均取引高
12.5K
1株当たり利益(TTM)
14.77
配当利回り
--
時価総額
$302.8B
RHHVFとは何ですか？
Roche Holding AG is a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 103,249 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.